tiprankstipranks
Trending News
More News >
Wanjia Group Holdings Ltd. (HK:0401)
:0401
Hong Kong Market

Wanjia Group Holdings Ltd. (0401) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Wanjia Group Holdings Ltd.

(0401)

Rating:46Neutral
Price Target:
Wanjia Group Holdings Ltd.'s overall stock score reflects significant challenges, particularly in financial performance and technical analysis. The consistent net losses and negative EBIT are major concerns, despite some revenue growth and a stable balance sheet. The bearish technical indicators and negative valuation metrics further weigh on the stock's attractiveness. Without earnings call insights or notable corporate events to provide additional context or positive outlook, the stock remains under pressure.

Wanjia Group Holdings Ltd. (0401) vs. iShares MSCI Hong Kong ETF (EWH)

Wanjia Group Holdings Ltd. Business Overview & Revenue Model

Company DescriptionWanjia Group Holdings Ltd. (0401) is a diversified investment holding company engaged in various business sectors including healthcare, money lending, and securities investment. The company operates primarily in Hong Kong and the People's Republic of China, with a focus on providing healthcare services, financial services, and investment opportunities.
How the Company Makes MoneyWanjia Group Holdings Ltd. generates revenue through multiple channels. Its healthcare segment earns income from the provision of medical and health-related services. In the financial services sector, the company makes money through its money lending operations, earning interest income from loans provided to individuals and businesses. Additionally, Wanjia Group engages in securities investment, which involves generating returns from buying and selling securities. The company may also form strategic partnerships and collaborations to enhance its service offerings and expand its market reach, contributing to its overall earnings.

Wanjia Group Holdings Ltd. Financial Statement Overview

Summary
Wanjia Group Holdings Ltd. faces profitability challenges with consistent net losses and negative EBIT. While revenue growth is present, it is not sufficient to overcome the company's operating inefficiencies. The balance sheet is stable, with low leverage and a strong equity position, but the negative return on equity highlights ongoing operational issues. Cash flow generation remains a relative strength, providing some financial stability amidst profitability concerns.
Income Statement
40
Negative
The company has shown fluctuating revenue growth, with a 4.3% increase in the latest year. However, profitability is a concern with consistently negative EBIT and net income over recent years. The gross profit margin remains stable at around 30%, but net profit margins have been negative, indicating operational challenges.
Balance Sheet
55
Neutral
The balance sheet shows moderate strength with a debt-to-equity ratio of 0.21, suggesting manageable leverage. However, the return on equity is negative due to net losses, and the equity ratio is 62.7%, reflecting a reasonable proportion of equity financing. The company maintains a positive net debt position, which is favorable.
Cash Flow
60
Neutral
The company has positive operating cash flow, but free cash flow growth is modest. The operating cash flow to net income ratio is high, indicating effective cash generation from operations, despite net losses. The company's ability to convert earnings into cash flow is a positive indicator in an otherwise challenging financial situation.
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue171.41M181.09M173.70M154.82M114.09M96.98M
Gross Profit54.50M54.74M56.94M54.23M41.34M25.35M
EBITDA-3.83M-29.02M16.40M-34.64M8.16M-2.19M
Net Income-35.67M-39.98M1.82M-51.00M-4.54M-20.74M
Balance Sheet
Total Assets117.10M117.10M173.45M191.82M223.59M206.70M
Cash, Cash Equivalents and Short-Term Investments18.23M18.23M9.88M5.77M25.10M24.80M
Total Debt15.60M15.60M25.17M20.99M22.12M23.53M
Total Liabilities41.91M41.91M53.22M63.72M52.51M48.37M
Stockholders Equity73.49M73.49M118.20M126.18M169.31M156.78M
Cash Flow
Free Cash Flow10.25M5.89M5.47M-4.86M-4.34M11.13M
Operating Cash Flow10.25M9.30M9.38M2.12M7.61M21.90M
Investing Cash Flow911.00K674.00K-3.84M-6.93M-11.84M-33.07M
Financing Cash Flow1.63M-1.04M-802.00K-14.97M4.33M7.34M

Wanjia Group Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.07
Price Trends
50DMA
0.08
Negative
100DMA
0.08
Negative
200DMA
0.07
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
36.05
Neutral
STOCH
<0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0401, the sentiment is Negative. The current price of 0.07 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.08, and below the 200-day MA of 0.07, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 36.05 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0401.

Wanjia Group Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$94.76B20.6113.20%2.43%-9.60%-27.18%
76
Outperform
$10.20B10.337.27%7.81%12.03%20.45%
75
Outperform
HK$29.76B16.8610.17%5.38%-8.91%-34.40%
69
Neutral
$95.33B50.246.14%1.50%7.63%-24.23%
60
Neutral
HK$15.58B5.65-7.43%4.32%11.60%-21.06%
46
Neutral
HK$40.90M-9.43%-3.12%-2869.57%
46
Neutral
HK$801.67M1.04
45.65%-81.70%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0401
Wanjia Group Holdings Ltd.
0.07
>-0.01
-12.50%
HK:0809
Global Bio-chem Technology Group Co. Ltd.
0.09
0.02
28.57%
HK:1177
Sino Biopharmaceutical
5.60
2.82
101.29%
HK:1093
CSPC Pharmaceutical Group
8.15
2.15
35.88%
HK:2343
Pacific Basin Shipping
2.12
-0.28
-11.67%
HK:0867
China Medical System Holdings
12.24
5.79
89.80%

Wanjia Group Holdings Ltd. Corporate Events

Wanjia Group Holdings Announces Registrar and Office Changes
Jan 7, 2025

Wanjia Group Holdings Limited has announced a change in its principal share registrar, transfer office, and registered office in the Cayman Islands, effective December 31, 2024. This strategic change is part of the company’s operational adjustments, as it continues to maintain its branch share registrar and transfer office in Hong Kong through Tricor Investor Services Limited.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 07, 2025